Examining interpregnancy intervals and maternal and perinatal health outcomes using U.S. vital records: Important considerations for analysis and interpretation

por Thoma, Marie E., De Silva, Dane A., MacDorman, Marian F.
Publicado 2018

Timing of delivery in a high-risk obstetric population: a clinical prediction model

por De Silva, Dane A., Lisonkova, Sarka, von Dadelszen, Peter, Synnes, Anne R., Magee, Laura A.
Publicado 2017

Determinants of magnesium sulphate use in women hospitalized at <29 weeks with severe or non-severe pre-eclampsia

por De Silva, Dane A., Proctor, Lily, von Dadelszen, Peter, McCoach, Meghan, Lee, Tang, Magee, Laura A.
Publicado 2017

Unexpected random urinary protein:creatinine ratio results–limitations of the pyrocatechol violet-dye method

por De Silva, Dane A, Halstead, Anne C, Côté, Anne-Marie, Sabr, Yasser, von Dadelszen, Peter, Magee, Laura A
Publicado 2013

MAGnesium sulphate for fetal neuroprotection to prevent Cerebral Palsy (MAG-CP)—implementation of a national guideline in Canada

por De Silva, Dane A., Synnes, Anne R., von Dadelszen, Peter, Lee, Tang, Bone, Jeffrey N., Magee, Laura A.
Publicado 2018

Magnesium sulphate for fetal neuroprotection: benefits and challenges of a systematic knowledge translation project in Canada

por Teela, Katherine C., De Silva, Dane A., Chapman, Katie, Synnes, Anne R., Sawchuck, Diane, Basso, Melanie, Liston, Robert M., von Dadelszen, Peter, Magee, Laura A.
Publicado 2015

Fetal, Infant and Maternal Outcomes among Women with Prolapsed Membranes Admitted before 29 Weeks Gestation

por Robertson, Julie E., Lisonkova, Sarka, Lee, Tang, De Silva, Dane A., von Dadelszen, Peter, Synnes, Anne R., Joseph, K. S., Liston, Robert M., Magee, Laura A.
Publicado 2016